Simpson EL, Kircik L, Blauvelt A, Kallender H, et al. Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy. J Dermatol 2023 Oct 13. doi: 10.1111/1346-8138.16975.
PMID: 37830436